PedAM
Pediatric Disease Annotations & Medicines
| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0023467|acute myeloid leukemia |
| Sentences | 14 |
| PubMedID- 23728608 | Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. |
| PubMedID- 25687068 | [analysis of prognosis in acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation]. |
| PubMedID- 25380682 | Contribution of non-infectious transplantation-related complications to the outcome of hematopoietic stem cell transplantation in patients with acute myeloid leukemia: a single institute analysis. |
| PubMedID- 25072307 | Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis. |
| PubMedID- 22476996 | Purpose: despite extensive study, the use of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (aml) vary considerably. |
| PubMedID- 22783362 | Chronic graft versus host disease with small bowel obstruction after unrelated hematopoietic stem cell transplantation in a patient with acute myeloid leukemia. |
| PubMedID- 23396805 | Allogeneic nk cells exhibit potent anti-tumor activities that are beneficial in the setting of hematopoietic stem cell transplantation into patients with acute myeloid leukemia (9). |
| PubMedID- 25550955 | Background: we performed a systematic review and meta-analysis to compare the clinical outcomes and toxicity of reduced-intensity conditioning (ric) and myeloablative conditioning (mac) allogeneic hematopoietic stem cell transplantation (allohsct) in patients with acute myeloid leukemia (aml) and myelodysplastic syndrome (mds). |
| PubMedID- 24767158 | [clinical outcome of flt3-itd (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation]. |
| PubMedID- 23341720 | Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia. |
| PubMedID- 26183077 | Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with acute myeloid leukemia (aml) and myelodysplastic syndromes (mds) represents a promising tool for predicting disease relapse, although its precise role in this setting remains unclear. |
| PubMedID- 26230954 | Leukemia relapse remains the top cause of death post allogeneic hematopoietic stem cell transplantation (allosct) in patients with acute myeloid leukemia (aml).1 once leukemia relapse occurs, the prognosis is generally poor with the overall 5-year survival of only 5% and medium time to death of 3–4 months.2, 3 treatment options in this population are extremely limited. |
| PubMedID- 26422713 | Cd25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplantation predicts relapse in patients with acute myeloid leukemia without complete remission. |
| PubMedID- 25876899 | [impact of human cytomegalovirus viremia on relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients]. |
Page: 1